| Primary |
| Malignant Melanoma |
63.3% |
| Metastatic Malignant Melanoma |
9.5% |
| Pain |
3.5% |
| Nausea |
3.0% |
| Prostate Cancer |
3.0% |
| Small Cell Lung Cancer Stage Unspecified |
2.0% |
| Prophylaxis |
1.9% |
| Diarrhoea |
1.8% |
| Lung Neoplasm Malignant |
1.7% |
| Hypertension |
1.5% |
| Anxiety |
1.4% |
| Constipation |
1.2% |
| Non-small Cell Lung Cancer |
1.2% |
| Insomnia |
1.0% |
| Premedication |
0.8% |
| Vomiting |
0.8% |
| Depression |
0.7% |
| Atrial Fibrillation |
0.6% |
| Hypersensitivity |
0.6% |
| Medical Diet |
0.6% |
|
| Diarrhoea |
13.4% |
| Vomiting |
11.1% |
| Pyrexia |
10.7% |
| Colitis |
6.5% |
| Dehydration |
5.8% |
| Neoplasm Malignant |
5.4% |
| Nausea |
4.9% |
| Sepsis |
3.9% |
| Malignant Neoplasm Progression |
3.8% |
| Abdominal Pain |
3.6% |
| Lipase Increased |
3.6% |
| Headache |
3.5% |
| Anaemia |
3.2% |
| Death |
3.2% |
| Renal Failure Acute |
3.2% |
| Hyponatraemia |
3.1% |
| Hypophysitis |
2.9% |
| Pain |
2.9% |
| Fatigue |
2.6% |
| Thrombocytopenia |
2.6% |
|
| Secondary |
| Malignant Melanoma |
36.0% |
| Product Used For Unknown Indication |
35.2% |
| Metastatic Malignant Melanoma |
5.6% |
| Drug Use For Unknown Indication |
5.0% |
| Diarrhoea |
3.0% |
| Prostate Cancer |
2.2% |
| Pain |
2.0% |
| Non-small Cell Lung Cancer |
1.9% |
| Prostate Cancer Metastatic |
1.8% |
| Back Pain |
1.0% |
| Constipation |
0.9% |
| Hypertension |
0.8% |
| Nausea |
0.6% |
| Peripheral Arterial Occlusive Disease |
0.6% |
| Depression |
0.6% |
| Diabetes Mellitus |
0.6% |
| Prophylaxis |
0.6% |
| Vitamin Supplementation |
0.6% |
| Anxiety |
0.5% |
| Convulsion |
0.5% |
|
| Vomiting |
11.3% |
| Joint Range Of Motion Decreased |
7.0% |
| Colitis |
6.3% |
| Pulmonary Embolism |
5.6% |
| Weight Decreased |
5.6% |
| Pneumonitis |
4.9% |
| Pyrexia |
4.9% |
| Rash |
4.9% |
| Sepsis |
4.9% |
| Urinary Tract Infection |
4.9% |
| Alanine Aminotransferase Increased |
4.2% |
| Atrial Fibrillation |
4.2% |
| Diarrhoea |
4.2% |
| Hypotension |
4.2% |
| Neoplasm Malignant |
4.2% |
| Swelling |
4.2% |
| Fatigue |
3.5% |
| Lipase Increased |
3.5% |
| Rash Maculo-papular |
3.5% |
| Temporal Arteritis |
3.5% |
|
| Concomitant |
| Metastatic Malignant Melanoma |
26.0% |
| Product Used For Unknown Indication |
18.3% |
| Malignant Melanoma |
12.2% |
| Acute Lymphocytic Leukaemia |
8.4% |
| Epilepsy |
3.8% |
| Pain |
3.8% |
| Colitis |
3.1% |
| Multiple Myeloma |
3.1% |
| Prostate Cancer |
3.1% |
| Brain Oedema |
2.3% |
| Neoplasm Malignant |
2.3% |
| Prostate Cancer Metastatic |
2.3% |
| Back Pain |
1.5% |
| Depression |
1.5% |
| Melanoma |
1.5% |
| Melanoma Recurrent |
1.5% |
| Metastasis |
1.5% |
| Oedema |
1.5% |
| Tumour Associated Fever |
1.5% |
| Deep Vein Thrombosis |
0.8% |
|
| Pyrexia |
13.8% |
| Angina Unstable |
10.3% |
| Death |
10.3% |
| Malignant Melanoma |
10.3% |
| Adenocarcinoma Pancreas |
3.4% |
| Adrenocortical Insufficiency Acute |
3.4% |
| Blood Creatinine Increased |
3.4% |
| Chills |
3.4% |
| Colitis |
3.4% |
| Decreased Appetite |
3.4% |
| Disease Progression |
3.4% |
| Drug Ineffective |
3.4% |
| Ecg Signs Of Myocardial Ischaemia |
3.4% |
| Heart Rate Increased |
3.4% |
| Hyperkeratosis |
3.4% |
| Hypopituitarism |
3.4% |
| Jaundice |
3.4% |
| Metastases To Bladder |
3.4% |
| Metastases To Central Nervous System |
3.4% |
| Nephritis Autoimmune |
3.4% |
|
| Interacting |
| Malignant Melanoma |
100.0% |
|
| Rash Maculo-papular |
100.0% |
|
